Latest Healthcare Research Reports

Tag: anticoccidial drugs market analysis

  • Anticoccidial Drugs Market Outlook 2025 – Insights for Executive and Strategic Planning

    Anticoccidial Drugs Market Outlook 2025 – Insights for Executive and Strategic Planning

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    How Fast Is The Anticoccidial Drugs Market Expected to Grow Between 2025 And 2029?

    In recent times, there’s been robust growth in the market size of anticoccidial drugs. Its expansion is projected from $1.27 billion in 2024 to $1.37 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%. The substantial growth in the past can be linked to a rise in global cases of coccidiosis, heightened ownership of pet animals, widespread prevalence of coccidiosis, its economic implications, and increasing concerns about the safety of food and animal health.

    What Growth Rate Is Anticipated for the Anticoccidial Drugs Market in the Coming Years?

    The market for anticoccidial drugs is projected to experience substantial growth in the coming years, increasing to $1.81 billion by 2029 with a 7.2% compound annual growth rate (CAGR). This future growth is believed to be due to several factors. These include the expansion of veterinary healthcare, the escalating occurrence of coccidiosis in animals, a rise in the usage of synthetic drugs, an increasing requirement for feed additives, and the growth in livestock production. During the forecast period, specific trends are expected to drive the growth. These trends include increasing demand spurred by newly emerging strains of coccidiosis, a movement towards natural and alternative treatment procedures, more stringent regulatory scrutiny that inspires innovation, a rise in customer preference for antibiotic-free poultry products, improvements in drug delivery technology, an intensified emphasis on preventive healthcare practices, and a broadening application scope in the aquaculture and companion animal sectors.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=15723&type=smp

    Who Are the Leading Companies in the Anticoccidial Drugs Market?

    Major companies operating in the anticoccidial drugs market are Johnson & Johnson, Merck and Co. Inc., Bayer AG, Novartis AG, Eli Lilly and Company Ltd., Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Intas Pharmaceuticals Ltd., Ceva Santé Animale S.A., Virbac S.A., Phibro Animal Health Corporation, Vetoquinol SA, Alpharma BVBA, Kepro B.V., Kemin Industries Inc., Tianjin Ringpu Bio-Technology Co. Ltd., Hester Biosciences Limited, Huvepharma AD, Biovet S.A., Lallemand Animal Nutrition, HIPRA, Impextraco NV, Venkateshwara Hatcheries Pvt Ltd

    What Are the Key Drivers of the Anticoccidial Drugs Market?

    The anticoccidial drug market is predicted to grow due to the escalating demand for meat proteins. These proteins found naturally in the flesh of animals, contain critical amino acids that play vital roles in bodily functions. Consumer preference for protein-enriched foods, driven by increased disposable income, urbanization, population growth, and dietary changes, is fuelling demand for meat proteins. Anticoccidial drugs play a key role in modern livestock rearing, supporting animal health and productivity, and enabling farmers to meet the growing demand for meat proteins in a sustainable and efficient way. The Organization for Economic Co-operation and Development, based in France, and the Food and Agriculture Organization, based in Italy, reported in July 2023 that despite an estimated increase of 2% in global average per capita meat demand from the base period of 2020-2022 to 2032, the FAO meat price index saw a 10% increase in 2022 due to limited export supplies. Thus, the anticoccidial drug market is poised for expansion due to the growing demand for meat proteins.

    Market Growth of Anticoccidial Drugs Driven by Upsurge in Poultry Farming

     

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=15723&type=smp

    What Are the Key Market Segments in the Anticoccidial Drugs Industry?

    The anticoccidial drugs market covered in this report is segmented –

    1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes

    2) By Drug Action: Coccidiostatic, Coccidiocidal

    3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals

    4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels

    Subsegments:

    1) By Ionophore: Monensin, Lasalocid, Salinomycin

    2) By Antibiotic: Tylosin, Lincomycin, Bacitracin

    3) By Sulphonamides: Sulfadimethoxine, Sulfaquinoxaline

    4) By Chemical Derivative: Diclazuril, Clopidol

    5) By Other Drug Classes: Amprolium, Robenidine

    What Are the Latest Trends in the Anticoccidial Drugs Market?

    Top companies in the anticoccidial drugs market are centering on the development of innovative solutions such as synthetic coccidiostat with an aim to bolster efficacy, eradicate resistance growth, and to tackle evolving obstacles in poultry and livestock management. Synthetic coccidiostat is a chemically structured compound intended for the prevention or control of coccidiosis by restricting the growth and propagation of coccidia parasites in animals. For example, in March 2023, Zoetis, an animal health firm based in the US, introduced Avi-Deccox, a newly formulated synthetic coccidiostat for controlling coccidiosis in broiler chickens. This specific product attacks the pathogens Eimeria acervulina and Eimeria tenella which cause considerable financial damages in poultry farming. Similar to its initial version, Deccox, Avi-Deccox uses decoquinate as its primary active element. It addresses the escalating problem of resistance associated with the frequent utilization of ionophores in poultry farming by utilizing a different method of action, yielding a more efficient short-term knock-down effect.

    Access The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report

    What Are the Key Regional Markets in the Anticoccidial Drugs Industry?

    North America was the largest region in the anticoccidial drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    Purchase The Full Report Today:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15723

    This Report Delivers Insight On:

    1. How big is the anticoccidial drugs market, and how is it changing globally?

    2. Who are the major companies in the anticoccidial drugs market, and how are they performing?

    3. What are the key opportunities and risks in the anticoccidial drugs market right now?

    4. Which products or customer segments are growing the most in the anticoccidial drugs market?

    5. What factors are helping or slowing down the growth of the anticoccidial drugs market?

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 2071930708

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Next-Gen Anticoccidial Drugs : Market Forecast, Transformation, and Long-Term Trajectories

    Discover trends, market shifts, and competitive outlooks for the anticoccidial drugs industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

    #How Has the Anticoccidial Drugs Market Growth Performance Trended Historically, And What Lies Ahead?3

    The market size of anticoccidial drugs has seen robust growth in the past few years. It is projected to increase from $1.27 billion in 2024 to $1.37 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%. The phenomenal growth in the past years was due to factors including a global rise in coccidiosis cases, heightened adoption of pets, widespread prevalence of coccidiosis, economic factors, and growing public concern over food safety and animal health.

    The market for anticoccidial drugs is predicted to experience robust expansion in the coming years, reaching a valuation of $1.81 billion by 2029 at a Compound Annual Growth Rate (CAGR) of 7.2%. Several factors contribute to this expected growth during the forecast period, including the expansion of veterinary care, the rising incidence of coccidiosis in animals, increased usage of synthetic drugs, escalating demand for feed additives, and growth in livestock production. Key trends anticipated for this forecast period include increased demand due to new strains of coccidiosis, a move towards natural and alternative treatments, innovation encouraged by intensified regulatory scrutiny, preferential consumer behavior towards antibiotic-free poultry products, advancements in drug delivery technology, amplified emphasis on preventative healthcare, and growth in applications within the aquaculture and pet industries.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=15723&type=smp

    Which Major Market Drivers Are Expected to Boost the Growth Potential of the Anticoccidial Drugs Market?

    The escalating demand for meat proteins is set to fuel the expansion of the anticoccidial drug sector. Naturally found in animal flesh, meat proteins consist of a variety of amino acids crucial for numerous physiological functions. The increase in meat protein demand is due to factors such as population growth, increased disposable income, urbanization, and shifts in nutrition intake towards protein-laden foods. Anticoccidial medications are crucial instruments in contemporary livestock farming. These medicines aid in maintaining the animals’ wellbeing and productivity, ensuring that farmers can fulfill the mounting demand for meat proteins effectively and sustainably. For instance, a July 2023 report published by the France-based Organization for Economic Co-operation and Development (OECD) and the Italy-based Food and Agriculture Organization, indicated that even though there was an anticipated rise of 2% in average global meat demand per person from 2020-2022 to 2032, the FAO meat price index skyrocketed by 10% in 2022 due to a drop in export supplies. Therefore, the escalating demand for meat proteins is propelling the expansion of the anticoccidial drug sector. The increase in poultry farming is set to stimulate the growth of the anticoccidial drug sector. Poultry farming involves rearing tamed birds, such as chickens, turkeys, ducks, and geese, for meat, feather, and egg production. The boost in poultry farming is a result of augmenting demands for protein, advancements in farming approaches, and global trade expansion. Anticoccidial medications are often mixed into poultry feed or water as a preventative measure to safeguard the birds from coccidiosis, particularly during their early, most susceptible growth stages. For instance, in June 2023, according to the US-based USDA Economic Research Service, the total sales of the poultry industry crested to $76.9 billion in 2022, a substantial surge of 67% from the preceding year. Therefore, the boost in poultry farming propels the expansion of the anticoccidial drug sector.

    Which Key Market Segments Comprise the Anticoccidial Drugs Market and Drive Its Revenue Growth?

    The anticoccidial drugs market covered in this report is segmented –

    1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes

    2) By Drug Action: Coccidiostatic, Coccidiocidal

    3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals

    4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels

    Subsegments:

    1) By Ionophore: Monensin, Lasalocid, Salinomycin

    2) By Antibiotic: Tylosin, Lincomycin, Bacitracin

    3) By Sulphonamides: Sulfadimethoxine, Sulfaquinoxaline

    4) By Chemical Derivative: Diclazuril, Clopidol

    5) By Other Drug Classes: Amprolium, Robenidine

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=15723&type=smp

    Which Areas Are Leading Regions in the Anticoccidial Drugs Market Expansion Across the Globe?

    North America was the largest region in the anticoccidial drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    What Key Market Trends and Innovations Are Shaping the Future of the Anticoccidial Drugs Industry?

    Leading firms in the anticoccidial drugs market are concentrating on the creation of ground-breaking solutions, including synthetic coccidiostat, to increase efficacy, reduce resistance progression, and meet the rising challenges in poultry and livestock management. Synthetic coccidiostat, a chemically created compound, is utilized to inhibit coccidiosis by restricting the growth and multiplication of coccidia parasites in animals. For instance, in March 2023, Zoetis, an animal health organization based in the US, introduced Avi-Deccox, a newly reformulated synthetic coccidiostat designed to keep coccidiosis in broiler chickens under control. This product is specifically aimed at the pathogens Eimeria acervulina and Eimeria tenella, which cause significant financial harm in poultry farming. The active ingredient in this product is decoquinate, just like its predecessor, Deccox. Avi-Deccox tackles the increasing problem of resistance associated with the repeated use of ionophores in poultry farming, employing a different approach to provide a more effective short-term elimination effect.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report

    How Is the Anticoccidial Drugs Market Conceptually Defined?

    Anticoccidial drugs are a class of medications used to prevent and treat coccidiosis, a parasitic disease of the intestinal tract caused by protozoa of the genus Eimeria. These drugs work by inhibiting various stages of the coccidia life cycle, controlling the infection, and preventing the severe intestinal damage and related symptoms associated with the disease. Anticoccidial drugs are commonly used in veterinary medicine, particularly poultry, to enhance health and productivity by managing this widespread and economically significant condition.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15723

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Top Growth Trends in the Anticoccidial Drugs Market: Insights into Market Size and Opportunities for 2025-2034

    Top Growth Trends in the Anticoccidial Drugs Market: Insights into Market Size and Opportunities for 2025-2034

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    Which Major Market Drivers Are Expected to Boost the Growth Potential of the Anticoccidial Drugs Market?

    Anticoccidial drugs market is expected to see a surge as the demand for meat proteins rises. Meat proteins, which are found in animal flesh and include several different types of amino acids crucial to bodily function, have seen increased demand due to larger populations, increased disposable incomes, urbanization, and a shift in dietary preferences to foods high in protein. Anticoccidial drugs play a crucial role in the modern livestock farming industry by ensuring the health and productivity of animals, helping farmers to meet the rising demand for meat proteins in an efficient and sustainable way. A report published by the Organization for Economic Co-operation and Development (OECD), a France-based intergovernmental organization, and the Food and Agriculture Organization, an Italy-based specialized agency, in July 2023 found that despite an expected 2% increase in per capita meat demand globally from the base period of 2020-2022 to 2032, the FAO meat price index increased by 10% in 2022 due to reduced export supplies. As such, the increasing demand for meat proteins is boosting the growth of the anticoccidial drug market. The anticoccidial drugs market is also set to benefit from the growth in poultry farming. Poultry farming, which involves rearing domesticated birds like chickens, turkeys, ducks and geese for their meat, eggs, and feathers, has seen a rise due to increased protein demand, enhanced farming methods, and the expansion of global trade. Anticoccidial drugs are typically included in poultry feed or water as a preventive measure to protect the birds from coccidiosis, particularly during their early and most vulnerable stages of growth. According to the USDA Economic Research Service, an American government administration, in June 2023, the total annual sales for the poultry sector hit $76.9 billion in 2022, representing a 67% increase from the previous year. As such, the increase in poultry farming is contributing to the growth of the anticoccidial drug market.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=15723&type=smp

    #How Does the ProjectedAnticoccidial Drugs Market Growth Compare Over the Forecast Period?

    In recent years, the anticoccidial drugs market has seen substantial growth. The market size is projected to increase from $1.27 billion in 2024 to $1.37 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%. The upward trend during the historical period can be traced back to the global rise in coccidiosis cases, the widespread adoption of pet animals, the high prevalence of coccidiosis, its economic impact, as well as growing concerns over food safety and animal health.

    The market for anticoccidial drugs is set to experience robust growth in the coming years, scaling up to $1.81 billion in 2029, with a CAGR of 7.2%. The expansion of this market over the forecast period is due to factors such as the surge in veterinary healthcare, the escalation in the outbreak of coccidiosis in animals, intensified synthetic drug usage, increased demand for feed additives, and a spike in livestock production. Key trends during this predictive period include an increase in demand attributable to the development of new coccidiosis strains, a shift towards natural and alternate treatment procedures, more stringent regulatory examination spurring innovation, a shift in customer choice towards poultry products free of antibiotics, advancements in drug administration technologies, a greater emphasis on preventive health measures, and broadening usage in the fields of aquaculture and companion animal sectors.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15723

    What Are the Key Market Innovations in theAnticoccidial Drugs Market Over the Coming Years?

    Major firms operating in the anticoccidial drugs marketplace primarily concentrate on developing innovative solutions like synthetic coccidiostat, aiming to improve effectiveness, reduce resistance buildup, and tackle new challenges in poultry and livestock care. Synthetic coccidiostat is a chemically produced compound that helps to prevent or control coccidiosis by inhibiting the proliferation of coccidia parasites in animals. For example, in March 2023, Zoetis, an animal health enterprise based in the US, introduced Avi-Deccox, a reengineered synthetic coccidiostat developed to manage coccidiosis in broiler chickens. This product specifically targets the pathogens Eimeria acervulina and Eimeria tenella, known for causing significant economic damage in poultry farming. The active ingredient in this product is decoquinate, just like its forerunner, Deccox. Avi-Deccox deals with the increasing resistance problem associated with the overuse of ionophores in poultry farming by implementing a different mechanism of action, offering a more potent short-term knock-down effect.

    Who Are the Top Companies Driving Innovation and Growth in theAnticoccidial Drugs Market?

    Major companies operating in the anticoccidial drugs market are Johnson & Johnson, Merck and Co. Inc., Bayer AG, Novartis AG, Eli Lilly and Company Ltd., Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Intas Pharmaceuticals Ltd., Ceva Santé Animale S.A., Virbac S.A., Phibro Animal Health Corporation, Vetoquinol SA, Alpharma BVBA, Kepro B.V., Kemin Industries Inc., Tianjin Ringpu Bio-Technology Co. Ltd., Hester Biosciences Limited, Huvepharma AD, Biovet S.A., Lallemand Animal Nutrition, HIPRA, Impextraco NV, Venkateshwara Hatcheries Pvt Ltd

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report

    Which Key Market Segments Comprise the Anticoccidial Drugs Market and Drive Its Revenue Growth?

    The anticoccidial drugs market covered in this report is segmented –

    1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes

    2) By Drug Action: Coccidiostatic, Coccidiocidal

    3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals

    4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels

    Subsegments:

    1) By Ionophore: Monensin, Lasalocid, Salinomycin

    2) By Antibiotic: Tylosin, Lincomycin, Bacitracin

    3) By Sulphonamides: Sulfadimethoxine, Sulfaquinoxaline

    4) By Chemical Derivative: Diclazuril, Clopidol

    5) By Other Drug Classes: Amprolium, Robenidine

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=15723&type=smp

    Which Regions Are Emerging as Leaders in the Anticoccidial Drugs Market?

    North America was the largest region in the anticoccidial drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    Browse Through More Reports Similar to the Global Anticoccidial Drugs Market 2025, By The Business Research Company:

    Ovarian Cancer Drugs Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/ovarian-cancer-drugs-global-market-report

    Kidney Cancer Drugs Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/kidney-cancer-drugs-global-market-report

    Prostate Cancer Drugs Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/prostate-cancer-drugs-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Anticoccidial Drugs Growth Forecast 2025-2034: Trends, Opportunities, and Key Insights You Need to Know

    Anticoccidial Drugs Growth Forecast 2025-2034: Trends, Opportunities, and Key Insights You Need to Know

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What is the Predicted CAGR for the Anticoccidial Drugs Market Over the Forecast Period of 2025 to 2034?

    There has been a robust expansion in the anticoccidial drugs market in the past few years. The market value is expected to surge from $1.27 billion in 2024 to $1.37 billion in 2025, marking a Compound Annual Growth Rate (CAGR) of 7.6%. Factors such as the rising global incidence of coccidiosis, an increase in pet animal ownership, a high rate of coccidiosis prevalence, economic implications, and heightened concerns about the safety of animal food and health have contributed to the growth seen in the historical period.

    The market for anticoccidial drugs is predicted to experience substantial growth in the upcoming years. It is anticipated to increase to $1.81 billion in 2029, displaying a compound annual growth rate (CAGR) of 7.2%. Factors contributing to this expected escalation during the forecast period include the surge in veterinary healthcare, a higher incidence of coccidiosis in animals, the escalating usage of synthetic drugs, the burgeoning requirement for feed additives, and a rise in livestock production. In the prediction period, crucial trends encompass increasing demand due to emerging strains of coccidiosis, a trend towards adopting natural and alternative remedies, heightened regulation sparking innovation, a rising preference among consumers for poultry products free from antibiotics, developments in the technology for drug delivery, increased attention on preventive health measures, and broadening applications in the sectors of aquaculture and companion animal.

    Which Macro and Microeconomic Factors Are Accelerating the Growth of the Anticoccidial Drugs Market?

    The anticoccidial drug market is poised to grow as the demand for meat proteins accelerates. Meat proteins, found naturally in animal flesh and composed of a variety of essential amino acids, are increasingly popular due to population growth, rising disposable income, urbanization, and a shift toward protein-heavy diets. Anticoccidial drugs are a critical component in contemporary livestock farming as they promote animal health and productivity, vital for meeting the escalating demand for meat proteins in an efficient and sustainable manner. For example, an OECD report in July 2023 indicated that in contrast to the 2% increase in global average per capita meat demand projected from the 2020-2022 period to 2032, the FAO meat price index spiked by 10% in 2022 due to lower export supplies. Hence, the escalating demand for meat proteins is fueling the expansion of the anticoccidial drug market. In relation to the anticoccidial drugs market driver, an increasing trend in poultry farming is anticipated to push forward the growth of the anticoccidial drug market. Poultry farming involves the farming of domesticated birds such as chickens, turkeys, ducks, and geese for their meat, feathers, or eggs. This rise in poultry farming is encouraged by a growing demand for protein, enhanced farming techniques, and the widening scope of international trade. These birds are often given anticoccidial drugs through their feed or water as a preemptive measure to shield them from coccidiosis during their early and most susceptible growth stages. For example, as per the U.S. based USDA Economic Research Service, the poultry industry reported total sales of $76.9 billion in 2022, marking a 67% jump from the previous year. As such, the increasing trend of poultry farming is stimulating the anticoccidial drug market’s growth.

    Request Your Free Anticoccidial Drugs Market Report Sample Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=15723&type=smp

    Who Are the Top Companies Driving Innovation and Growth in the Anticoccidial Drugs Market?

    Major companies operating in the anticoccidial drugs market are:

    • Johnson & Johnson

    • Merck and Co. Inc.

    • Bayer AG

    • Novartis AG

    • Eli Lilly and Company Ltd.

    What Key Trends Are Currently Impacting the Anticoccidial Drugs Market’s Development?

    Leading organizations in the anticoccidial drugs market are concentrating their efforts on the creation of novel solutions such as synthetic coccidiostat. This aims to increase effectiveness, reduce the likelihood of resistance, and tackle emerging obstacles in poultry and livestock management. Synthetic coccidiostat, a chemically fabricated compound, is utilized to prevent or manage coccidiosis by arresting the coccidia parasites’ growth and breeding in animals. For instance, Zoetis, an animal health corporation based out of the US, introduced Avi-Deccox in March 2023. This reformulated synthetic coccidiostat concentrates on managing coccidiosis in broiler chickens. It specifically targets Eimeria acervulina and Eimeria tenella pathogens that cause considerable financial damages to poultry farming. Similar to the preceding Deccox, the product spotlights decoquinate as its potent component. By employing a varied action pathway, Avi-Deccox effectively counters the intensifying resistance problem associated with the recurring use of ionophores in poultry farming, leading to a more powerful short-term knock-down effect.

    Pre-order Your Report for Quick and Easy Delivery!

    https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report

    What Are the Main Segments of the Anticoccidial Drugs Market, and How Are They Evolving?

    The anticoccidial drugs market covered in this report is segmented –

    1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes

    2) By Drug Action: Coccidiostatic, Coccidiocidal

    3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals

    4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels

    Subsegments:

    1) By Ionophore: Monensin, Lasalocid, Salinomycin

    2) By Antibiotic: Tylosin, Lincomycin, Bacitracin

    3) By Sulphonamides: Sulfadimethoxine, Sulfaquinoxaline

    4) By Chemical Derivative: Diclazuril, Clopidol

    5) By Other Drug Classes: Amprolium, Robenidine

    Which Geographical Regions Are Pioneering Growth in the Anticoccidial Drugs Market?

    North America was the largest region in the anticoccidial drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    What Are the Defining Aspects of the Anticoccidial Drugs Market Landscape?

    Anticoccidial drugs are a class of medications used to prevent and treat coccidiosis, a parasitic disease of the intestinal tract caused by protozoa of the genus Eimeria. These drugs work by inhibiting various stages of the coccidia life cycle, controlling the infection, and preventing the severe intestinal damage and related symptoms associated with the disease. Anticoccidial drugs are commonly used in veterinary medicine, particularly poultry, to enhance health and productivity by managing this widespread and economically significant condition.

    Browse Through More Similar Reports By The Business Research Company:

    Ovarian Cancer Drugs Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/ovarian-cancer-drugs-global-market-report

    Kidney Cancer Drugs Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/kidney-cancer-drugs-global-market-report

    Prostate Cancer Drugs Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/prostate-cancer-drugs-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Global Anticoccidial Drugs Market Analysis: Size, Drivers, Trends, Opportunities, And Strategies

    Global Anticoccidial Drugs Market Analysis: Size, Drivers, Trends, Opportunities, And Strategies

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Anticoccidial Drugs Market from 2024 to 2033?

    The anticoccidial drugs market has experienced strong growth in recent years. It is projected to increase from $1.19 billion in 2023 to $1.27 billion in 2024, with a CAGR of 7.0%. Contributing factors include a higher incidence of coccidiosis globally, increased pet ownership, the high prevalence of coccidiosis, its economic impact, and growing safety concerns regarding food and animal health.

    The anticoccidial drugs market is projected to grow to $1.69 billion by 2028 with a CAGR of 7.3%. This growth is linked to the increasing prevalence of coccidiosis in animals and the demand for feed additives. Key trends include a shift towards natural treatment methods and advancements in drug delivery technologies.

    Claim Your Free Sample of the Global Anticoccidial Drugs Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=15723&type=smp

    What Key Factors Are Fueling the Growth of the Anticoccidial Drugs Market?

    The rising demand for meat proteins is expected to propel the anticoccidial drug market. Meat proteins are vital for health, with increased demand stemming from population growth and changing dietary preferences. Anticoccidial drugs are essential for maintaining livestock health and productivity. The OECD reported that global meat protein consumption is forecast to increase by 14% by 2030, with significant growth in beef, pork, poultry, and sheep meat. Hence, the demand for meat proteins is fueling the anticoccidial drug market.

    What Are the Major Segments of the Anticoccidial Drugs Market?

    1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes

    2) By Drug Action: Coccidiostatic, Coccidiocidal

    3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals

    4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels

    What New Trends Are Transforming the Anticoccidial Drugs Market?

    Companies in the anticoccidial drugs market are creating zoalene-based products to combat coccidiosis in livestock. In May 2021, Elanco introduced ZoaShielda, a reliable solution for poultry producers to effectively manage coccidiosis.

    Order Now for Fast Delivery of Your Anticoccidial Drugs Market Report!

    https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report

    Which Regions Are Driving Growth in the Anticoccidial Drugs Market?

    North America was the largest region in the anticoccidial drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    The Anticoccidial Drugs Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the anticoccidial drugs market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Anticoccidial Drugs Market Include

    1. Anticoccidial Drugs Market Executive Summary

    2. Anticoccidial Drugs Market Segments

    3. Anticoccidial Drugs Market Size And Template Market Growth Rate

    4. Key Anticoccidial Drugs Market Trends

    5. Major Anticoccidial Drugs Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Anticoccidial Drugs Market

    26. Top Anticoccidial Drugs Companies

    27. Anticoccidial Drugs Market Opportunities And Strategies

    28. Anticoccidial Drugs Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Bladder Cancer Drugs Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/bladder-cancer-drugs-global-market-report

    Blood Cancer Drugs Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report

    Brain Tumor Drugs Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/brain-tumor-drugs-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

    Industry: Pharmaceuticals

    Meta Keywords: anticoccidial drugs market size, anticoccidial drugs market outlook, anticoccidial drugs market research, anticoccidial drugs market data, anticoccidial drugs market growth, anticoccidial drugs market analysis, anticoccidial drugs market segments, anticoccidial drugs market forecast, anticoccidial drugs market overview, anticoccidial drugs market, anticoccidial drugs market growth, anticoccidial drugs market insights

    The Business Research Company offers the anticoccidial drugs market research report 2024 with industry size, share, segments and market growth

    Global Anticoccidial Drugs Market, Global Anticoccidial Drugs Market Report, Global Anticoccidial Drugs Market Trends, Global Anticoccidial Drugs Market Size

  • Global Anticoccidial Drugs Market Analysis: Size, Drivers, Trends, Opportunities, And Strategies

    Global Anticoccidial Drugs Market Analysis: Size, Drivers, Trends, Opportunities, And Strategies

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Anticoccidial Drugs Market from 2024 to 2033?
    The anticoccidial drugs market has experienced strong growth in recent years. It is projected to increase from $1.19 billion in 2023 to $1.27 billion in 2024, with a CAGR of 7.0%. Contributing factors include a higher incidence of coccidiosis globally, increased pet ownership, the high prevalence of coccidiosis, its economic impact, and growing safety concerns regarding food and animal health.

    The anticoccidial drugs market is projected to grow to $1.69 billion by 2028 with a CAGR of 7.3%. This growth is linked to the increasing prevalence of coccidiosis in animals and the demand for feed additives. Key trends include a shift towards natural treatment methods and advancements in drug delivery technologies.

    Claim Your Free Sample of the Global Anticoccidial Drugs Market Report Today!
    https://www.thebusinessresearchcompany.com/sample.aspx?id=15723&type=smp

    What Key Factors Are Fueling the Growth of the Anticoccidial Drugs Market?
    The rising demand for meat proteins is expected to propel the anticoccidial drug market. Meat proteins are vital for health, with increased demand stemming from population growth and changing dietary preferences. Anticoccidial drugs are essential for maintaining livestock health and productivity. The OECD reported that global meat protein consumption is forecast to increase by 14% by 2030, with significant growth in beef, pork, poultry, and sheep meat. Hence, the demand for meat proteins is fueling the anticoccidial drug market.

    What Are the Major Segments of the Anticoccidial Drugs Market?
    1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes
    2) By Drug Action: Coccidiostatic, Coccidiocidal
    3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals
    4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels

    What New Trends Are Transforming the Anticoccidial Drugs Market?
    Companies in the anticoccidial drugs market are creating zoalene-based products to combat coccidiosis in livestock. In May 2021, Elanco introduced ZoaShielda, a reliable solution for poultry producers to effectively manage coccidiosis.

    Order Now for Fast Delivery of Your Anticoccidial Drugs Market Report!
    https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report

    Which Regions Are Driving Growth in the Anticoccidial Drugs Market?
    North America was the largest region in the anticoccidial drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    The Anticoccidial Drugs Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the anticoccidial drugs market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Anticoccidial Drugs Market Include

    1. Anticoccidial Drugs Market Executive Summary
    2. Anticoccidial Drugs Market Segments
    3. Anticoccidial Drugs Market Size And Template Market Growth Rate
    4.  Key Anticoccidial Drugs Market Trends
    5. Major Anticoccidial Drugs Market Drivers
    ……
    25. Key Mergers And Acquisitions In The Anticoccidial Drugs Market
    26. Top Anticoccidial Drugs Companies
    27. Anticoccidial Drugs Market Opportunities And Strategies
    28. Anticoccidial Drugs Market, Conclusions And Recommendations
    29. Appendix

    Discover Related Reports by The Business Research Company:
    Bladder Cancer Drugs Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/bladder-cancer-drugs-global-market-report

    Blood Cancer Drugs Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report

    Brain Tumor Drugs Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/brain-tumor-drugs-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:
    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Anticoccidial Drugs Market Key Insights 2024-2033

    Global Anticoccidial Drugs Market Key Insights 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    Strong Growth in Recent Years

    • Market Expansion: The anticoccidial drugs market has experienced significant growth recently, increasing from $1.19 billion in 2023 to $1.27 billion in 2024. This reflects a robust compound annual growth rate (CAGR) of 7.0%.
    • Drivers of Growth: Key factors contributing to this growth include a rising incidence of coccidiosis globally, increased pet adoption, and heightened concerns about food safety and animal health.

    Future Growth Projections

    • Market Outlook: Looking ahead, the anticoccidial drugs market is expected to reach $1.69 billion by 2028, with a CAGR of 7.3%.
    • Growth Drivers: This future growth will be driven by factors such as expanding veterinary healthcare, rising coccidiosis cases, and increasing use of synthetic drugs. Additionally, the demand for feed additives and livestock production is expected to contribute significantly.
    • Emerging Trends: Anticipated trends include a surge in demand due to new coccidiosis strains, a shift towards natural treatments, and advancements in drug delivery technologies.

    View More On The Anticoccidial Drugs Market Report 2024 – https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report

    Impact of Growing Meat Protein Demand

    • Rising Protein Consumption: The global demand for meat proteins is forecast to increase by 14% by 2030, driven by population growth and changing dietary preferences.
    • Role of Anticoccidial Drugs: These drugs play a crucial role in maintaining animal health and productivity, ensuring a stable supply of meat proteins. For example, OECD reports anticipate increases in meat consumption across various types, including beef, pork, poultry, and sheep meat.
    • Market Implications: This growing demand directly impacts the anticoccidial drug market, fostering its expansion to support the meat industry’s needs.

    Surge in Poultry Farming

    • Poultry Sector Growth: The rise in poultry farming, due to increased protein demand and improved farming techniques, has significantly influenced the anticoccidial drug market.
    • Economic Impact: For instance, poultry sector sales in the U.S. reached $76.9 billion in 2022, marking a 67% increase from the previous year.
    • Market Contribution: Anticoccidial drugs are critical in poultry farming for preventing coccidiosis, thus supporting the sector’s growth and the overall market for these drugs.

    Innovative Zoalene-Based Solutions

    • Development Focus: Major companies are innovating with zoalene-based solutions to enhance efficacy and address emerging challenges in animal health management.
    • Example: Elanco Animal Health introduced ZoaShielda in May 2021, a zoalene-based solution designed to manage coccidiosis in poultry effectively, offering flexibility and reliability.
    • Market Impact: These innovations are helping to meet the evolving needs of poultry producers and drive market growth.

    Market Segmentation

    • Drug Classes: The market is segmented into Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, and other classes.
    • Drug Actions: Anticoccidial drugs function as either Coccidiostatic or Coccidiocidal.
    • Applications: They are applied in poultry, swine, fish, cattle, and companion animals.
    • Distribution Channels: These drugs are distributed through veterinary hospitals, retail pharmacies, and other channels.

    Regional Insights

    • Current Leader: North America was the largest region in the anticoccidial drugs market in 2023.
    • Future Growth: Asia-Pacific is anticipated to be the fastest-growing region in the forecast period, driven by increasing agricultural activities and rising demand for animal health solutions.

    The anticoccidial drugs market is poised for continued growth, driven by factors such as rising meat protein demand, increased poultry farming, and ongoing innovations in drug development. As the market evolves, it will continue to play a crucial role in ensuring animal health and meeting global food supply needs.

    Request A Sample Of The Global Anticoccidial Drugs Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=15723&type=smp